Australian Pharmacist

Pharmacists are asked to lead the shift from reliever to inhaled corticosteroid regimens and to minimise use of oral corticosteroids.

How pharmacists can support patients in the end-of-life period.

This week pharmacists will see a suite of regulatory and funding changes take effect. Here are the six key updates pharmacists need to know before...

Pharmacy’s ‘go to’ reference – the APF – describes expected practice, not just best practice. Common ailments are no exception.

The journey through the Australian healthcare system has been long and hard for this pharmacist patient with Hypermobile Ehlers-Danlos syndrome.

The discontinuation of several insulin products will leave many patients struggling to adjust to new medicine strengths and devices.